N-(5-acetyl-1,3-thiazol-2-yl)-2,2-dimethylpropanamide, 95.0%, 5g

(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole], 97%, 100mg

tert-Butyl 4-hydroxybenzylcarbamate, 95.0%, 250mg

(R)-1-(4-CHLORO-3-FLUOROPHENYL)ETHANE-1,2-DIOL, 95.0%, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxybutanoic acid, 95.0%, 250mg

N,N-DIETHYL-5-METHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-AMINE, 95.0%, 50mg

(4R)-3-[(tert-butoxy)carbonyl]-1,3-thiazolidine-4-carboxylic acid, 99.0%, 25g

Gallic acid, min. 98%, pa, ACS, anhydrous, 250 g, glass packaging

SPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONE, 95.0%, 1g

Methyl 3-amino-5-tert-butylthiophene-2-carboxylate, 99.0%, 5g

tert-Butyl (3-amino-3-oxopropyl)carbamate, 97%, 250mg

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-S-trityl-L-cysteine, 97%, 100mg

7-BROMO-3,4-DIHYDRO-2H-BENZO[B][1,4]THIAZINE, 97.0%, 250mg